Filing Details
- Accession Number:
- 0001127602-19-018976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-17 16:07:50
- Reporting Period:
- 2019-05-15
- Accepted Time:
- 2019-05-17 16:07:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501185 | A David Lemoine | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-05-15 | 874 | $102.49 | 9,148 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 8,752 | $26.00 | 17,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-16 | 8,752 | $106.92 | 9,148 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-16 | 8,752 | $0.00 | 8,752 | $26.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-09 | No | 4 | M | Direct |
Footnotes
- This transaction represents the sale of shares intended to approximate the associated tax liability resulting from the vesting of restricted stock units on April 30, 2019.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2019.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $106.89 to $107.105. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a three year vesting period with one-half of the total award vesting on February 9, 2017, one-quarter of the total award vesting on February 9, 2018 and one-quarter of the total award vesting on February 9, 2019, subject to continued service as a director or consultant.
Billionaire Hedge Funds
